CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Purchase | +74,582 | $25.54 | $1.9M | 38,811,515 |
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Option exercise · Non-Qualified Stock Options (right to buy) | −12,500 | 0 | ||
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Option exercise · Non-Qualified Stock Options (right to buy) | −12,500 | 0 | ||
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Purchase | +7,645 | $24.46 | $187K | 3,529,258 |
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Purchase | +82,148 | $24.46 | $2.0M | 38,567,129 |
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Purchase | +3,781 | $24.80 | $94K | 3,533,039 |
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Purchase | +40,632 | $24.80 | $1.0M | 38,607,761 |
| 2023-05-17 | Kihara James Principal Accounting Officer | Option exercise | +5,947 | 11,144 | ||
| 2023-05-17 | Kihara James Principal Accounting Officer | Option exercise | +5,947 | 17,091 | ||
| 2023-05-17 | Kihara James Principal Accounting Officer | Sale | −5,947 | $22.50 | $134K | 11,144 |
| 2023-05-17 | Kihara James Principal Accounting Officer | Option exercise · Restricted Stock Units | −5,947 | 9,913 | ||
| 2023-05-17 | Kihara James Principal Accounting Officer | Option exercise · Restricted Stock Units | −5,947 | 9,913 | ||
| 2023-05-17 | Schneyer Mark C. EVP, Chief Financial Officer | Option exercise | +14,869 | 22,346 | ||
| 2023-05-17 | Schneyer Mark C. EVP, Chief Financial Officer | Option exercise | +14,869 | 37,215 | ||
| 2023-05-17 | Schneyer Mark C. EVP, Chief Financial Officer | Sale | −15,310 | $22.50 | $344K | 21,905 |
| 2023-05-17 | Schneyer Mark C. EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −14,869 | 24,782 | ||
| 2023-05-17 | Schneyer Mark C. EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −14,869 | 24,782 | ||
| 2023-05-17 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise | +14,869 | 24,356 | ||
| 2023-05-17 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise | +14,869 | 39,225 | ||
| 2023-05-17 | Teehan Brendan EVP, COO, Head of Commercial | Sale | −14,869 | $22.50 | $335K | 24,356 |
Page 20 of 63 · 1,260 trades